sodium phytate has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellasi, A; Bover, J; Bushinsky, D; Chertow, GM; Garg, R; Gillotti, K; Gold, A; Ketteler, M; Padgett, C; Perelló, J; Raggi, P; Rodriguez, M; Salcedo, C; Sinha, S | 1 |
| Banon-Maneus, E; Campistol, JM; Canals, AZ; Ferrer, MD; Garg, R; Gold, A; Lazo-Rodriguez, M; Miller, S; Perelló, J; Perez, MM; Salcedo, C | 1 |
1 trial(s) available for sodium phytate and Disease Exacerbation
| Article | Year |
|---|---|
Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis: Results of a Randomized Phase 2b Study.
Topics: Aged; Aortic Valve; Coronary Artery Disease; Disease Progression; Double-Blind Method; Durapatite; Europe; Female; Heart Valve Diseases; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vascular Calcification | 2020 |
1 other study(ies) available for sodium phytate and Disease Exacerbation
| Article | Year |
|---|---|
A novel assay to measure calcification propensity: from laboratory to humans.
Topics: Animals; Aorta; Biomarkers; Calcinosis; Calciphylaxis; Calcium Phosphates; Clinical Laboratory Techniques; Clinical Trials, Phase II as Topic; Disease Progression; Dose-Response Relationship, Drug; Humans; Linear Models; Myocardium; Phytic Acid; Randomized Controlled Trials as Topic; Rats; Renal Dialysis; Spectrophotometry; Vitamin D | 2020 |